• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNAi 沉默 p15 表达增强肝癌细胞对顺铂的耐药性。

Silence of p15 expression by RNAi enhances cisplatin resistance in hepatocellular carcinoma cells.

机构信息

Department of Digestive Diseases, the Second Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China.

出版信息

Bosn J Basic Med Sci. 2012 Feb;12(1):4-9. doi: 10.17305/bjbms.2012.2523.

DOI:10.17305/bjbms.2012.2523
PMID:22364296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4362417/
Abstract

The insensitivity of hepatocellular carcinoma to chemotherapy is associated with alternation in tumor cell cycling. This current study was designed to investigate the impact of p15 silencing on the sensitivity of Human hepatocellular carcinoma HepG2 cells to cisplatin. HepG2/CDDP/1.6 and HepG2/CDDP/2.0 cells were induced by culture with increased doses of cisplatin and their sensitivities to cis-Diamine dichloroplatinum (CDDP) were determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). The impacts of p15 silencing on the cell cycling and P-gp expression were characterized by flow cytometry, RT-PCR and Western blot assays, respectively. Knockdown of p15 expression dramatically reduced the relative levels of p15 expression and the frequency of phase G1, promoting cell cycling. On the other hand, knockdown of p15 expression significantly up-regulated the expression of P-glycoprotein (P-gp) in HepG2/CDDP/2.0 cells, associated with the increased resistance of HepG2 cells to CDDP in vitro. In conclusion, the p15 may be a critical regulator of the development of CDDP resistance in HepG2 cells.

摘要

肝癌对化疗的不敏感性与肿瘤细胞周期的改变有关。本研究旨在探讨 p15 沉默对人肝癌 HepG2 细胞对顺铂敏感性的影响。用增加剂量的顺铂培养诱导 HepG2/CDDP/1.6 和 HepG2/CDDP/2.0 细胞,并通过 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐 (MTT) 测定其对顺二氨二氯铂 (CDDP) 的敏感性。通过流式细胞术、RT-PCR 和 Western blot 分析分别研究 p15 沉默对细胞周期和 P-糖蛋白表达的影响。p15 表达的敲低显著降低了 p15 表达的相对水平和 G1 期的频率,促进了细胞周期。另一方面,p15 表达的敲低显著上调了 HepG2/CDDP/2.0 细胞中 P-糖蛋白 (P-gp) 的表达,与 HepG2 细胞对 CDDP 的体外耐药性增加有关。综上所述,p15 可能是 HepG2 细胞中 CDDP 耐药发展的关键调节剂。

相似文献

1
Silence of p15 expression by RNAi enhances cisplatin resistance in hepatocellular carcinoma cells.RNAi 沉默 p15 表达增强肝癌细胞对顺铂的耐药性。
Bosn J Basic Med Sci. 2012 Feb;12(1):4-9. doi: 10.17305/bjbms.2012.2523.
2
Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.抑制JNK信号通路通过下调P-糖蛋白的表达增加肝癌细胞对顺铂的敏感性。
Eur Rev Med Pharmacol Sci. 2016;20(6):1098-108.
3
Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.顺铂耐药人肝癌细胞系的特征及耐药机制
Saudi Med J. 2009 Jan;30(1):35-40.
4
Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin.锌原卟啉IX增强肝癌细胞对顺铂的化疗反应。
World J Gastroenterol. 2014 Jul 14;20(26):8572-82. doi: 10.3748/wjg.v20.i26.8572.
5
Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.蛋白磷酸酶2A-B55δ在微小RNA-133b的调控下增强人肝细胞癌的化疗敏感性。
J Exp Clin Cancer Res. 2016 Apr 14;35:67. doi: 10.1186/s13046-016-0341-z.
6
Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.康莱特增强顺铂抑制肝癌的疗效通过抑制 CKLF1 介导的 NF-κB 通路和调节转运体介导的药物外排。
J Ethnopharmacol. 2021 Jan 10;264:113388. doi: 10.1016/j.jep.2020.113388. Epub 2020 Sep 10.
7
Long interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinoma.长散在核元件 ORF-1 蛋白促进肝癌的增殖和化疗耐药性。
World J Gastroenterol. 2013 Feb 21;19(7):1068-78. doi: 10.3748/wjg.v19.i7.1068.
8
Astragaloside IV enhances cisplatin chemosensitivity in hepatocellular carcinoma by suppressing MRP2.黄芪甲苷通过抑制 MRP2 增强肝癌细胞对顺铂的化疗敏感性。
Eur J Pharm Sci. 2020 May 30;148:105325. doi: 10.1016/j.ejps.2020.105325. Epub 2020 Apr 4.
9
Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.载顺铂-齐墩果酸碳酸钙纳米粒对肝癌细胞的协同作用增强凋亡,降低肝毒性。
Int J Nanomedicine. 2019 May 28;14:3753-3771. doi: 10.2147/IJN.S196651. eCollection 2019.
10
Changes in the Expression of Various Transporters as Influencing Factors of Resistance to Cisplatin.
Anticancer Res. 2017 Oct;37(10):5477-5484. doi: 10.21873/anticanres.11977.

引用本文的文献

1
Measuring the differential expression of the major hypermethylated tumor suppressor genes in tissues of primary hepatocellular carcinoma.检测原发性肝细胞癌组织中主要高甲基化肿瘤抑制基因的差异表达。
J Genet Eng Biotechnol. 2024 Sep;22(3):100394. doi: 10.1016/j.jgeb.2024.100394. Epub 2024 Jun 5.
2
High Expression of G9a Induces Cisplatin Resistance in Hepatocellular Carcinoma.G9a的高表达诱导肝癌细胞对顺铂耐药。
Cell J. 2023 Feb 1;25(2):118-125. doi: 10.22074/cellj.2022.557564.1077.
3
ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA.锌指蛋白2通过干扰核转录因子Y亚基A抑制多药耐药基因1,增强化疗药物对肝癌细胞的细胞毒性。
Oncotarget. 2015 Jan 20;6(2):1049-63. doi: 10.18632/oncotarget.2832.
4
Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection.乙型肝炎病毒感染的肝细胞癌中p14(ARF)、RB和INK4基因家族的启动子高甲基化
Tumour Biol. 2014 Mar;35(3):2795-802. doi: 10.1007/s13277-013-1372-0. Epub 2013 Nov 20.
5
Effects of urotensin II and its specific receptor antagonist urantide on rat vascular smooth muscle cells.尾加压素 II 及其特异性受体拮抗剂尿速肽对大鼠血管平滑肌细胞的影响。
Bosn J Basic Med Sci. 2013 May;13(2):78-83. doi: 10.17305/bjbms.2013.2369.

本文引用的文献

1
Cyclins and their related proteins in pituitary tumourigenesis.细胞周期蛋白及其相关蛋白在垂体肿瘤发生中的作用。
Mol Cell Endocrinol. 2010 Sep 15;326(1-2):25-9. doi: 10.1016/j.mce.2010.03.017. Epub 2010 Mar 27.
2
Expression and significance of tumor drug resistance related proteins and beta-catenin in esophageal squamous cell carcinoma.肿瘤耐药相关蛋白及β-连环蛋白在食管鳞状细胞癌中的表达及意义
Chin J Cancer. 2010 Mar;29(3):300-5. doi: 10.5732/cjc.009.10599.
3
Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.酪丝缬肽(YSV)三肽对耐药人肝癌细胞系BEL-7402/5-FU多药耐药的逆转作用
Cancer Lett. 2008 Sep 28;269(1):101-10. doi: 10.1016/j.canlet.2008.04.033. Epub 2008 Jun 5.
4
Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer.P15(INK4B)和SMAD4在进展期胃癌中的免疫组化表达
Anticancer Res. 2008 Mar-Apr;28(2A):1079-83.
5
p15Ink4b: dual function in myelopoiesis and inactivation in myeloid disease.p15Ink4b:在髓系造血中的双重功能及在髓系疾病中的失活
Blood Cells Mol Dis. 2008 May-Jun;40(3):406-9. doi: 10.1016/j.bcmd.2007.09.005. Epub 2007 Oct 29.
6
Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs.产生耐药表型的多种途径:编码基因或启动子区域的突变、易位、缺失和扩增、表观遗传变化以及微小RNA。
Drug Resist Updat. 2007 Feb-Apr;10(1-2):59-67. doi: 10.1016/j.drup.2007.02.002. Epub 2007 Mar 9.
7
Short interfering RNAs as a tool for cancer gene therapy.短干扰RNA作为癌症基因治疗的一种工具。
Cancer Gene Ther. 2005 Mar;12(3):217-27. doi: 10.1038/sj.cgt.7700791.
8
Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer.通过小干扰RNA沉默hdm2癌基因可抑制p53依赖的人类乳腺癌。
Cancer Gene Ther. 2004 Nov;11(11):748-56. doi: 10.1038/sj.cgt.7700753.
9
Cyclin-dependent kinases regulate the antiproliferative function of Smads.细胞周期蛋白依赖性激酶调节Smads的抗增殖功能。
Nature. 2004 Jul 8;430(6996):226-31. doi: 10.1038/nature02650.
10
The RNAi revolution.RNA干扰革命。
Nature. 2004 Jul 8;430(6996):161-4. doi: 10.1038/430161a.